Fulphila prescribing information
WebJul 28, 2024 · Fulphila is used in cancer patients to increase the production of white blood cells to help prevent infections and neutropenia due to cancer treatment (chemotherapy). Neutropenia occurs when there is a low amount of the white blood cells known as … WebInjection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only. 4 CONTRAINDICATIONS NYVEPRIA is contraindicated in patients with a history of serious allergic reactions to pegfilgrastim products or filgrastim products. Reactions have included anaphylaxis [see Warnings and Precautions (5.3)]. 5 WARNINGS AND PRECAUTIONS
Fulphila prescribing information
Did you know?
WebNov 14, 2024 · Fulphila is a medicine used in cancer patients to help with neutropenia (low levels of neutrophils, a type of white blood cell), which is a common side effect of cancer … WebOn June 4, 2024, the Food and Drug Administration approved Fulphila (pegfilgrastim-jmdb, Mylan GmbH) as a biosimilar to Neulasta (pegfilgrastim, Amgen, Inc.) to decrease the chance of infection as ...
WebFor further information, please refer to the Prescribing Information and/or Drug Monograph for Fulphila. REFERENCES • Fulphila [Prescribing Information]. Zurich, Switzerland: Mylan GmbH; March 2024. Library Commercial NSA Yes Yes No Part D Effective: N/A Created: 10/22 Commercial Effective: 11/01/22 Client Approval: 10/22 … WebJul 28, 2024 · Fulphila is used in cancer patients to increase the production of white blood cells to help prevent infections and neutropenia due to cancer treatment (chemotherapy). …
WebFulphila is a clear, colorless, preservative-free solution available as: • Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only. 4 CONTRAINDICATIONS … WebOct 1, 2024 · Fulphila is a clear, colorless, preservative-free solution available as: • Injection: 6 mg/0.6 mL in a single-dose prefilled syringe for manual use only. Contraindications. Fulphila is contraindicated in …
WebApr 4, 2024 · Dosing information. Pegfilgrastim dosing information for patients with cancer receiving myelosuppressive chemotherapy Pegfilgrastim 6 mg administered …
WebCigna covers pegfilgrastim products (Fulphila, Fylnetra, Neulasta, Nyvepria, Udenyca, Stimufend, Ziextenzo) as medically necessary when the following criteria are met for FDA Indications or Other Uses ... 5. ™Nyvepria subcutaneous injection [prescribing information]. New York, NY: Pfizer; June 2024. 6. The NCCN Hematopoietic Cell ... meatless appetizers recipesWebDec 14, 2024 · Neulasta (pegfilgrastim) is prescribed to help prevent serious infection from chemotherapy for certain cancers, and from a certain form of radiation sickness. It’s a biologic drug that comes as an... peggy lee fever release dateWebFULPHILA®(pegfilgrastim-jmdb) is a man-made form of granulocyte colony-stimulating factor (G-CSF). G-CSF is a substance produced by the body. It stimulates the growth of … peggy lee fever bass tabWebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE SOMAVERT is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum insulin-like growth factor-I (IGF-I) levels. peggy lee fever yearWebinformation) supporting that member has met all approval criteria. It is the policy of Managed Health Services (MHS) that Neulasta, Fulphila, Udenyca, and Ziextenzo are medically necessary when the following criteria are met: I. Initial Approval Criteria A. Chemotherapy-Induced Neutropenia (must meet all): 1. Diagnosis of non-myeloid … meatless athleteWebUDENYCA ® (pegfilgrastim-cbqv) is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in patients with non … peggy lee happy holidaypeggy lee find a grave